ResMed

ResMed CEO Mick Farrell Weighs in on Health Tech Investing

ResMed CEO Mick Farrell Weighs in on Health Tech Investing

Wednesday, December 28, 2016

U.S. News & World Report

U.S. News & World Report’s Dawn Reiss spoke with ResMed CEO Mick Farrell on investing in health technology in 2017 and specifically the growing importance of healthcare data, analytics and algorithms.

“‘The importance of collecting remote data from digital health devices and providing connected care will change the way health care is delivered and how patients are managed,’ says Michael ‘Mick’ Farrell, CEO of ResMed in San Diego. ‘If we can truly understand all of the points in which patients interact with their therapies and the steps along the way in which physicians, payers and providers need to intervene, data analytics can improve the quality of care and increase efficiency so that patients receive the optimal treatment at the precise moment of need.’

This is ‘well beyond the overused term of big data,’ Farrell says. ‘It is really about algorithms that can discern actionable information that can improve patient outcomes,’ he says.”

Read the full story here.